KMKevin Marsh

Kevin Marsh

*This is an algorithmically generated author record based on publicly available information.

Kevin Marsh has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PREFACE

    by Kevin Marsh

    BASE-INSTANCE is the online home of leading journals and conference proceedings from BASE-INSTANCE Publishing and BASE-INSTANCE Member Societies

  • Immune effector mechanisms in malaria

    by K. Marsh, S. Kinyanjui

    SUMMARY: That humans in endemic areas become immune to malaria offers encouragement to the idea of developing protective vaccines. However natural immunity is relatively inefficient, being bought at the cost of substantial childhood mortality, and current vaccines are only partially protective. Understanding potential targets and mechanisms of protective immunity is important in the development and evaluation of future vaccines. Some of the problems in identifying such targets and mechanisms in humans naturally exposed to malaria may stem from conceptual and methodological issues related to defining who in a population is susceptible, problems in defining immune responsiveness at single time points and issues related to antigenic polymorphism, as well as the failure of many current approaches to examine functional aspects of the immune response. Protective immune responses may be directed to the pre erythrocytic parasite, to the free merozoite of the blood stage parasite or to new antigens induced on the infected red cell surface. Tackling the methodological issues of defining protection and immune response, together with studies that combine functional assays with new approaches such as allelic exchange and gene knock out offer opportunities for better defining key targets and mechanisms.


  • Open Access

    Plasmodium falciparumAntigenic Variation: Relationships between In Vivo Selection, Acquired Antibody Response, and Disease Severity

    by Peter C. Bull, Arnab Pain, Francis M. Ndungu, Samson M. Kinyanjui, David J. Roberts, Christopher I. Newbold, Kevin Marsh

    BackgroundVariant surface antigens (VSA) on Plasmodium falciparum–infected erythrocytes are potentially important targets of immunity to malaria. We previously identified a VSA phenotype—VSA with a high frequency of antibody recognition (VSAFoRH)—that is associated with young host age and severe malaria. We hypothesized that VSAFoRH are positively selected by host molecules such as intercellular adhesion molecule 1 (ICAM1) and CD36 and dominate in the absence of an effective immune response. Here, we assessed, in 115 Kenyan children, the potential role played by in vivo selection pressures in either favoring or selecting against VSAFoRH among parasites that cause malaria MethodsWe tested for associations between VSAFoRH and (1) the repertoire of VSA antibodies carried by children at the time of acute malaria and (2) polymorphisms in ICAM1 (K29M) and CD36 (T188G) that could potentially reduce the positive selection of VSAFoRH ResultsAn expected negative association between VSA antibody repertoire and VSAFoRH was observed in children with nonsevere malaria. However, this association did not extend to children with severe malaria, many of whom apparently had well-developed VSA antibody responses despite being infected by parasites expressing VSAFoRH. There was no evidence for involvement of CD36 or ICAM1 in positive selection of VSAFoRH. On the contrary, a weak positive association between carriage of the CD36 (T188G) allele and VSAFoRH was observed in children with severe malaria ConclusionThe association between the VSAFoRH parasite phenotype and severe malaria cannot be explained simply in terms of the total repertoire of VSA antibodies carried at the time of acute disease


  • Open Access

    Clinical algorithms for malaria diagnosis lack utility among people of different age groups

    by Tabitha W. Mwangi, Mahfudh Mohammed, Hiza Dayo, Robert W. Snow, Kevin Marsh

    Summary: We conducted a study to determine whether clinical algorithms would be useful in malaria diagnosis among people living in an area of moderate malaria transmission within Kilifi District in Kenya. A total of 1602 people of all age groups participated. We took smears and recorded clinical signs and symptoms (prompted or spontaneous) of all those presenting to the study clinic with a history of fever. A malaria case was defined as a person presenting to the clinic with a history of fever and concurrent parasitaemia. A set of clinical signs and symptoms (algorithms) with the highest sensitivity and specificity for diagnosing a malaria case was selected for the age groups ≤5 years, 6–14 years and ≥15 years. These age‐optimized derived algorithms were able to identify about 66% of the cases among those μl of blood would be sent home without treatment. Clinical algorithms therefore appear to have little utility in malaria diagnosis, performing even worse in the older age groups, where avoiding unnecessary use of anti‐malarials would make more drugs available to the really needy population of children under 5 years of age.


  • Improving malaria home treatment by training drug retailers in rural Kenya

    by V. M. Marsh, W. M. Mutemi, A. Willetts, K. Bayah, S. Were, A. Ross, K. Marsh

    Recent global malaria control initiatives highlight the potential role of drug retailers to improve access to early effective malaria treatment. We report on the findings and discuss the implications of an educational programme for rural drug retailers and communities in Kenya between 1998 and 2001 in a study population of 70,000. Impact was evaluated through annual household surveys of over-the-counter (OTC) drug use and simulated retail client surveys in an early (1999) and a late (2000) implementation area. The programme achieved major improvements in drug selling practices. The proportion of OTC anti-malarial drug users receiving an adequate dose rose from 8% (n = 98) to 33% (n = 121) between 1998 and 1999 in the early implementation area. By 2001, and with the introduction of sulphadoxine pyrimethamine group drugs in accordance with national policy, this proportion rose to 64% (n = 441) across the early and late implementation areas. Overall, the proportion of shop-treated childhood fevers receiving an adequate dose of a recommended anti-malarial drug within 24 h rose from 1% (n = 681) to 28% (n = 919) by 2001. These findings strongly support the inclusion of private drug retailers in control strategies aiming to improve prompt effective treatment of malaria.


  • Open Access

    Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa

    by Edwin Ochong, Alexis Nzila, Serah Kimani, Gilbert Kokwaro, Theonest Mutabingwa, William Watkins, Kevin Marsh


    • 1 September 1999
      • Vol. 41, 241-6

    Malaria transmission and morbidity.

    by K Marsh, R W Snow

    Stable malaria endemicity is maintained over a wide range of transmission intensities in sub-Saharan Africa. This paper considers variations in the clinical manifestations and their consequences with differences in transmission intensity. Epidemiological approaches to malarial disease have concentrated on two clinical syndromes, severe malarial anaemia and cerebral malaria. Within an area the mean age of children with severe malarial anaemia is always lower than that of those with cerebral malaria. In areas of higher malaria transmission children, on average, encounter malaria at a younger age and the mean age of clinical cases is lower. Malarial anaemia tends therefore to be relatively more important under high transmission settings and cerebral malaria tends to gain in importance under lower transmission settings. In a number of studies the total load of malaria morbidity, whether measured as none severe malaria in the community or as severe malaria admitted to hospital, is low under stable low transmission conditions but is at its highest under moderate intensities of transmission. Thereafter it reaches a plateau, or even falls, at the highest transmission intensities. It is not known whether the same is true for mortality in communities living under different transmission settings. Possible implications for changes in patterns of morbidity and mortality following interventions which lower malaria transmission are discussed. It is concluded that such interventions should play an important role in integrated malaria control programmes but that these should involve concomitant introduction of other interventions, in order to minimise the possible risks of a reduced effect as the immune response of the population re-equilibrates in the face of reduced challenge.